Arklin SRL
The score of Arklin shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +343 % Total assets +1921 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Arklin's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 10 Jun 2025
- Year ended 31 Dec 2023filed on 13 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
Arklin's financial analysis
- Solvency14.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Arklin
Arklin's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0787.351.671
- VAT number
- BE0787351671
- Peppol
- Registered · 0208:0787351671 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Jun 2022
- Registered office
- 3270 Scherpenheuvel-Zichem
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Arklin (SRL) has been based in Scherpenheuvel-Zichem since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 27,122 € and equity of 80,994 €; its revenue is not published. Its solvency stands at 14.0%, below the median of its sector (44.2%).
Companies similar to Arklin
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Sint-Dimpna Retail sale of pharmaceutical products Geel · balance sheet 539,460 €
- Lunsiefar Retail sale of pharmaceutical products Overijse · balance sheet 839,787 €
- Apone Retail sale of pharmaceutical products Hemiksem · balance sheet 653,679 €
- Pharmacie DU Stuyvenbergh Retail sale of pharmaceutical products Brussels · balance sheet 766,510 €
- VdC Invest Retail sale of pharmaceutical products Lierde · balance sheet 660,114 €
- Lidefarma Retail sale of pharmaceutical products Lierde · balance sheet 495,027 €
- Talpa Farma Retail sale of pharmaceutical products Anderlecht · balance sheet 547,932 €
- Kesters Pharma Invest Retail sale of pharmaceutical products Houthalen-Helchteren · balance sheet 469,134 €
Frequently asked questions about Arklin
What is the revenue of Arklin?
Arklin files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Arklin?
In Belgium, the VAT number is the company number prefixed with BE: BE0787351671 for Arklin, if the company is VAT-registered. Its company number (CBE) is 0787.351.671.
Where is the registered office of Arklin?
According to the CBE register, the registered office of Arklin is in 3270 Scherpenheuvel-Zichem.
What is the equity of Arklin?
At the close of the 2025 financial year, the equity of Arklin amounts to 80,994 €, a solvency of 14.0% of total assets.
Who manages Arklin?
The register lists 1 active mandates at Arklin. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Arklin
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →